Nature Sub-Journal: Li Yulong’s team develops a new type of fluorescent probe to achieve accurate detection of dynamic changes in serotonin in vivo
Who will be the first popular type of medical consortium to test the water with the volume procurement model?
Heavy | Binhui Bio-Clinical Cooperation Agency Announces Phase I/II Clinical Data of Oncolytic Herpes Simplex Virus Type II OH2 Injection
New medicine for the treatment of type 1 diabetes-TTP399 efficacy and safety results announced!
66% of diabetics die from this type of disease!
The "three brothers" of Parkinson's disease, cancer, and type 2 diabetes are originally in the same line
Takeda Pharmaceutical’s one-type or one-year “rare” or original sin
Arthritis Rheumatol: Type I interferon plays a key role in the development of cardiovascular disease in patients with systemic lupus erythematosus
New results help type 1 female "sugar friends" nurture healthy babies
Diabetes Care: Comparison of young patients with familial and sporadic type 1 diabetes
Sci Adv: The "three brothers" of Parkinson's disease, cancer, and type 2 diabetes are originally in the same line
Diabetes Care: The correlation between type 1 diabetes and eating disorders
Nat Commun: Type I interferon promotes the occurrence and development of patients with systemic lupus erythematosus
Hypertension: The relationship between the types of antihypertensive drugs and cardiovascular outcomes in HIV-infected hypertensive patients
R&D | Current status of the prevention and application of probiotics in type 2 diabetes
In recent years, microecological regulators have made great progress in regulating the intestinal microecology and improving
Long prescription for comments: 8 types of drugs were excluded, 4 cases were terminated
A few days ago, the National Health Commission publicly solicited opinions from the public
20 types of inhalants are amazing! Can these two types of metabolic surgery cure type 2 diabetes? NEJM: Lumasiran, an interfering RNA for the treatment of primary type 1 hyperoxuria Diabetes Care: The new hypoglycemic drug imiglitazone effectively improves HbA1c in patients with type 2 diabetes Contact Us Time of Update: 2021-04-14
Medical News, April 2nd.
Recently, new progress has been made in the research Time of Update: 2021-04-14
*Only for medical professionals to read
Time of Update: 2021-04-13
>Primary type 1 hypergrassuria (PH1) is a rare genetic disease. Excessive hepatic oxalate secretion leads to kidney stones, nephrocalcinosis, renal failure, and systemic oxalic
Time of Update: 2021-04-13
Compared with placebo, imiglitazone can significantly improve the HbA1c of Japanese T2DM patients, and its safety is similar to that of placebo.
The source of this page with content of products and services is from Internet,
which doesn't represent Echemi's opinion. If you have any queries, please write
to firstname.lastname@example.org. It will be replied within 5 days.
Moreover, if you find any instances of plagiarism from the page, please send email to email@example.com with relevant evidence.Trending Topics
Paints and Coatings Market
Latest Medical News
Feed Industry News
Medical World News
Plant Extracts News
Medical Research Articles
Study of Nervous System
Food Flavorings News
Medical Science News
Digestive System Information
Natural Products News
Amino Acids Research
Medicines Company News
Coating Additive Market
Pigment and Filler News
Food Coloring Articles
Leavening Agent News
Chinese Herbs Uses
Acidity Regulators Knowledge
20 types of inhalants are amazing!
Can these two types of metabolic surgery cure type 2 diabetes?
NEJM: Lumasiran, an interfering RNA for the treatment of primary type 1 hyperoxuria
Diabetes Care: The new hypoglycemic drug imiglitazone effectively improves HbA1c in patients with type 2 diabetes